These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 10987289

  • 1. Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators.
    Rusyn I, Yamashina S, Segal BH, Schoonhoven R, Holland SM, Cattley RC, Swenberg JA, Thurman RG.
    Cancer Res; 2000 Sep 01; 60(17):4798-803. PubMed ID: 10987289
    [Abstract] [Full Text] [Related]

  • 2. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
    Woods CG, Burns AM, Bradford BU, Ross PK, Kosyk O, Swenberg JA, Cunningham ML, Rusyn I.
    Toxicol Sci; 2007 Aug 01; 98(2):366-74. PubMed ID: 17483499
    [Abstract] [Full Text] [Related]

  • 3. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
    Rose ML, Germolec D, Arteel GE, Schoonhoven R, Thurman RG.
    Chem Res Toxicol; 1997 Oct 01; 10(10):1198-204. PubMed ID: 9348444
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643.
    Glauert HP, Eyigor A, Tharappel JC, Cooper S, Lee EY, Spear BT.
    Toxicol Sci; 2006 Apr 01; 90(2):331-6. PubMed ID: 16434500
    [Abstract] [Full Text] [Related]

  • 5. WY-14 643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes.
    Rusyn I, Tsukamoto H, Thurman RG.
    Carcinogenesis; 1998 Jul 01; 19(7):1217-22. PubMed ID: 9683180
    [Abstract] [Full Text] [Related]

  • 6. Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators.
    Rose ML, Rivera CA, Bradford BU, Graves LM, Cattley RC, Schoonhoven R, Swenberg JA, Thurman RG.
    Carcinogenesis; 1999 Jan 01; 20(1):27-33. PubMed ID: 9934846
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sustained formation of alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone radical adducts in mouse liver by peroxisome proliferators is dependent upon peroxisome proliferator-activated receptor-alpha, but not NADPH oxidase.
    Woods CG, Burns AM, Maki A, Bradford BU, Cunningham ML, Connor HD, Kadiiska MB, Mason RP, Peters JM, Rusyn I.
    Free Radic Biol Med; 2007 Feb 01; 42(3):335-42. PubMed ID: 17210446
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reactive oxygen species derived from NADPH oxidase system is not essential for liver regeneration after partial hepatectomy.
    Ueno S, Campbell J, Fausto N.
    J Surg Res; 2006 Dec 01; 136(2):260-5. PubMed ID: 17046793
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.
    Tawfik A, Sanders T, Kahook K, Akeel S, Elmarakby A, Al-Shabrawey M.
    Invest Ophthalmol Vis Sci; 2009 Feb 01; 50(2):878-84. PubMed ID: 18806296
    [Abstract] [Full Text] [Related]

  • 15. Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators.
    Rose ML, Germolec DR, Schoonhoven R, Thurman RG.
    Carcinogenesis; 1997 Aug 01; 18(8):1453-6. PubMed ID: 9276615
    [Abstract] [Full Text] [Related]

  • 16. Novel role of oxidants in the molecular mechanism of action of peroxisome proliferators.
    Rusyn I, Rose ML, Bojes HK, Thurman RG.
    Antioxid Redox Signal; 2000 Aug 01; 2(3):607-21. PubMed ID: 11229371
    [Abstract] [Full Text] [Related]

  • 17. Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis.
    Peters JM, Rusyn I, Rose ML, Gonzalez FJ, Thurman RG.
    Carcinogenesis; 2000 Apr 01; 21(4):823-6. PubMed ID: 10753222
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643.
    Obourn JD, Frame SR, Bell RH, Longnecker DS, Elliott GS, Cook JC.
    Toxicol Appl Pharmacol; 1997 Aug 01; 145(2):425-36. PubMed ID: 9266817
    [Abstract] [Full Text] [Related]

  • 19. NADPH oxidase mediates interleukin-6 expression in cerulein-stimulated pancreatic acinar cells.
    Yu JH, Lim JW, Kim H, Kim KH.
    Int J Biochem Cell Biol; 2005 Jul 01; 37(7):1458-69. PubMed ID: 15833277
    [Abstract] [Full Text] [Related]

  • 20. Activation of peroxisome proliferator-activated receptor alpha enhances apoptosis in the mouse liver.
    Xiao S, Anderson SP, Swanson C, Bahnemann R, Voss KA, Stauber AJ, Corton JC.
    Toxicol Sci; 2006 Aug 01; 92(2):368-77. PubMed ID: 16687391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.